We, thus, postulated that the malignant-derived STIM1 score (i.e. average value in bulky tissues) can be utilized as a surrogate for malignant-cell-specific functional activation of STIM1 expression in bulky cancer specimens (Supplementary Figure S12). This evidence concerns the gene STIM1 and cancer.